OneMedNet Expands Multiple Revenue-Delivering Projects Under Evergreen Agreement With Top Medical Device Leader
OneMedNet (Nasdaq:ONMD) has expanded its partnership with one of the world's top five medical device companies through multiple revenue-generating projects under an evergreen master services agreement. The collaboration includes four distinct purchase orders focused on delivering regulatory-grade multimodal Real-World Data (RWD) to accelerate medical imaging AI model development.
The company leverages its iRWD™ network spanning over 1,750 provider sites to deliver comprehensive datasets that include advanced medical imaging data and complete patient histories. OneMedNet has already begun fulfilling these recent orders, demonstrating its efficient execution capabilities in providing curated, de-identified, and fit-for-purpose datasets for AI development, clinical trial enhancement, and healthcare outcome improvement.
OneMedNet (Nasdaq:ONMD) ha ampliato la collaborazione con una delle prime cinque aziende mondiali nel settore dei dispositivi medici mediante diversi progetti a reddito, stipulati nell'ambito di un accordo quadro evergreen. L'intesa comprende quattro ordini di acquisto distinti mirati a fornire Real-World Data multimodali di qualità regolatoria per accelerare lo sviluppo di modelli IA per l'imaging medico.
L'azienda sfrutta la sua rete iRWD™ che copre oltre 1.750 strutture fornitrici per mettere a disposizione dataset completi, comprensivi di immagini mediche avanzate e di storie cliniche complete. OneMedNet ha già iniziato a evadere questi ordini, dimostrando la propria capacità di esecuzione nell'offrire dataset curati, de-identificati e adeguati allo scopo per lo sviluppo di IA, il potenziamento di trial clinici e il miglioramento degli esiti sanitari.
OneMedNet (Nasdaq:ONMD) ha ampliado su alianza con una de las cinco principales compañías mundiales de dispositivos médicos mediante varios proyectos generadores de ingresos dentro de un acuerdo marco evergreen. La colaboración incluye cuatro órdenes de compra distintas centradas en suministrar datos del mundo real multimodales con calidad regulatoria para acelerar el desarrollo de modelos de IA en imagen médica.
La empresa aprovecha su red iRWD™ que abarca más de 1.750 centros proveedores para ofrecer conjuntos de datos completos que incluyen imágenes médicas avanzadas y historiales clínicos íntegros. OneMedNet ya ha comenzado a ejecutar estos pedidos, demostrando su capacidad para entregar conjuntos de datos curados, desidentificados y adecuados al propósito para el desarrollo de IA, la mejora de ensayos clínicos y el progreso de los resultados sanitarios.
OneMedNet (Nasdaq:ONMD)는 세계 상위 5개 의료기기 회사 중 하나와의 파트너십을 확대하여 에버그린 마스터 서비스 계약 하에 다수의 수익 창출 프로젝트를 진행하고 있습니다. 이번 협업에는 의료 영상 AI 모델 개발을 가속하기 위해 규제 수준의 다중 모달 Real-World Data(RWD)를 제공하는 네 가지 별도 구매 주문이 포함됩니다.
회사는 1,750개 이상의 제공 기관을 포괄하는 iRWD™ 네트워크를 활용해 고급 의료 영상 데이터와 전체 환자 병력을 포함한 포괄적인 데이터셋을 제공합니다. OneMedNet은 이미 최근 주문 이행을 시작했으며, AI 개발, 임상시험 강화 및 의료 성과 개선을 위한 목적에 맞게 큐레이션되고 비식별화된 데이터셋을 효율적으로 제공하는 역량을 입증했습니다.
OneMedNet (Nasdaq:ONMD) a renforcé son partenariat avec l'une des cinq principales entreprises mondiales de dispositifs médicaux via plusieurs projets générateurs de revenus dans le cadre d'un accord-cadre evergreen. La collaboration comprend quatre bons de commande distincts visant à fournir des Real-World Data multimodales de qualité réglementaire pour accélérer le développement de modèles d'IA en imagerie médicale.
L'entreprise s'appuie sur son réseau iRWD™ couvrant plus de 1 750 sites prestataires pour livrer des jeux de données complets incluant des images médicales avancées et des antécédents patients complets. OneMedNet a déjà commencé à exécuter ces commandes récentes, démontrant sa capacité à fournir efficacement des jeux de données sélectionnés, dé-identifiés et adaptés à l'usage pour le développement d'IA, l'amélioration des essais cliniques et l'optimisation des résultats de santé.
OneMedNet (Nasdaq:ONMD) hat seine Partnerschaft mit einem der fünf weltweit führenden Medizintechnikunternehmen ausgeweitet und führt im Rahmen eines Evergreen-Master-Service-Vertrags mehrere umsatzgenerierende Projekte durch. Die Zusammenarbeit umfasst vier separate Bestellungen, die darauf abzielen, regulatorisch verwertbare multimodale Real-World-Daten (RWD) bereitzustellen, um die Entwicklung von KI-Modellen für die medizinische Bildgebung zu beschleunigen.
Das Unternehmen nutzt sein iRWD™-Netzwerk mit mehr als 1.750 Anbieterstandorten, um umfassende Datensätze zu liefern, die fortgeschrittene medizinische Bilddaten und vollständige Patientenhistorien enthalten. OneMedNet hat mit der Ausführung dieser jüngsten Aufträge bereits begonnen und demonstriert damit seine effizienten Fähigkeiten, kuratierte, de-identifizierte und zweckgerechte Datensätze für die KI-Entwicklung, die Optimierung klinischer Studien und die Verbesserung von Behandlungsergebnissen bereitzustellen.
- Secured multiple revenue-generating projects with a top 5 global medical device leader
- Evergreen master services agreement provides ongoing business potential with no fixed term
- Extensive network coverage with over 1,750 provider sites
- Demonstrated ability to quickly execute and deliver on new orders
- Specific revenue figures and contract values not disclosed
- Heavy dependence on single large customer relationship
Insights
OneMedNet secures multiple revenue streams through expanded partnership with top-5 medical device leader, demonstrating strong market position in healthcare AI data.
OneMedNet's announcement represents a significant commercial expansion with one of healthcare's most influential players. The evergreen master services agreement is particularly valuable as it establishes an ongoing revenue relationship without a fixed termination date, reducing customer acquisition costs and providing greater revenue predictability.
The four separate purchase orders indicate diverse use cases for OneMedNet's real-world data, suggesting their platform has multiple applications within a single organization. This demonstrates product versatility and increases potential wallet share from each customer. The immediate commencement of delivery on these orders confirms operational readiness and suggests near-term revenue recognition.
What truly differentiates OneMedNet in the competitive healthcare data landscape is their multimodal data offering. By combining advanced medical imaging with comprehensive patient histories and clinical notes, they're delivering the contextual richness necessary for developing sophisticated AI models. This comprehensive approach addresses a critical challenge in healthcare AI development – the need for diverse, interconnected data types that reflect real-world clinical scenarios.
The company's network spanning 1,750+ provider sites represents a substantial competitive moat. Building such extensive provider relationships requires significant time investment and regulatory navigation, creating barriers to entry for competitors. The emphasis on regulatory-grade data quality further strengthens their market position, particularly for customers developing products requiring FDA or other regulatory approvals.
MINNEAPOLIS, Aug. 25, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leader in AI-powered Real-World Data (RWD), announces significant adoption by one of the world’s top five medical device leaders. Renowned for its cutting-edge diagnostic imaging systems, clinical software, and digital health solutions, this global innovator is recognized for advancing precision medicine and improving patient outcomes worldwide.
There is a master services agreement in place providing for an evergreen engagement with no fixed term. Current deliverables include four distinct purchase orders for OneMedNet’s Real-World Data, each focused on delivering diverse, regulatory grade multi modal data to accelerate innovation in medical imaging AI model development. These agreements reflect the strength, reliability, and clinical integrity of OneMedNet’s data, which meets the rigorous quality standards demanded by the world’s most trusted healthcare brands.
“Real-World Evidence can only be generated from comprehensive, multimodal data sets. OneMedNet is uniquely positioned to deliver not only advanced medical imaging data but also the full depth of patient histories and provider notes from our partners’ electronic health records,” said Aaron Green, President and CEO of OneMedNet. “Our ability to provide the most current, large-scale data across our growing partner network is what continues to drive repeat business and long-term customer trust.”
OneMedNet has already begun to fulfill these most recent orders, underscoring its ability to move from agreement to delivery quickly and effectively. The projects leverage OneMedNet’s expansive iRWD™ network, encompassing clinical data sourced from over 1,750 provider sites.
By delivering curated, de-identified, and fit-for-purpose datasets, OneMedNet empowers its customers to accelerate AI development, enhance clinical trial design, and improve healthcare outcomes at scale.
About OneMedNet Corporation
OneMedNet is revolutionizing how the world unlocks Real-World Data (RWD), harnessing the untapped potential of over 1,750 healthcare sites through its iRWD™ platform. This isn’t just data—it’s the lifeblood of innovation, from de-identified medical imaging to electronic health records, fueling breakthroughs for drugmakers, medical device pioneers, and AI visionaries. With a network spanning rare diseases, oncology, cardiology, and beyond, OneMedNet delivers precision insights that redefine patient care and power the next wave of healthcare disruption.
Beyond healthcare OneMedNet’s proprietary AI anonymizes data for industries like finance, retail, and telecom, unlocking endless possibilities—rigorously testing production system upgrades, de-risking complex projects, and securely sharing sensitive data by stripping out personal information. Learn more at www.onemednet.com.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements. All statements other than statements of historical facts contained in this press release are forward-looking statements. We base these forward-looking statements on our current expectations and projections about future events, which we derive from the information presently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; risks inherent with investing in Bitcoin, including Bitcoin’s volatility; and our ability to implement our Bitcoin treasury strategy and its effects on our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this press release to conform these statements to actual results or to changes in our expectations..
OneMedNet Contacts:
Michael Wong, VP Marketing
Email: michael.wong@onemednet.com
SOURCE: ONEMEDNET CORPORATION
FAQ
What new contracts did OneMedNet (ONMD) announce with the medical device company?
How many provider sites are in OneMedNet's iRWD™ network?
What type of data does OneMedNet (ONMD) provide to its customers?
How does OneMedNet's data help in healthcare development?
Who is the CEO of OneMedNet (ONMD)?
